Send to a Friend Font Size: Increase Decrease

FGEN and KYNB Related Headlines

Feb 23, 2026 05:10PM Kyntra Bio reports positive results from prostate cancer drug trial
Feb 23, 2026 05:10PM Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be P

FGEN and KYNB Related Press Releases

Feb 23, 2026 05:10PM Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be P

FGEN and KYNB Related SEC Filings